Clinical trial
A Prospective, Observational Study in Adults With Retinitis Pigmentosa (RP)
NCT06517940 is registered in ClinicalTrials.gov with Sumitomo Pharma America, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Observational Study in Adults With Retinitis Pigmentosa (RP)
- Lead sponsor
- Sumitomo Pharma America, Inc.
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- October 3, 2024
- Completion date
- April 24, 2026
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.